• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人前列腺癌中钾通道亚型的恶性程度依赖性表达

Malignancy grade-dependent expression of K+-channel subtypes in human prostate cancer.

作者信息

Ohya Susumu, Kimura Kazunori, Niwa Satomi, Ohno Akitoshi, Kojima Yoshiyuki, Sasaki Shoichi, Kohri Kenjiro, Imaizumi Yuji

机构信息

Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.

出版信息

J Pharmacol Sci. 2009 Jan;109(1):148-51. doi: 10.1254/jphs.08208sc. Epub 2009 Jan 8.

DOI:10.1254/jphs.08208sc
PMID:19129683
Abstract

K(+) channels are key molecules in the progression of several cancer types and considered to be potential targets for cancer therapy. We examined the gene expressions of voltage-gated (K(v)), Ca(2+)-activated (K(Ca)), and two-pore domain (K(2P)) K(+)-channel subtypes in needle-biopsy samples of human prostate cancer (PCa) by real-time PCR and compared them with those in PCa epithelial cell lines. The expression of K(v)1.3, K(Ca)1.1, K(Ca)3.1, and K(2P)1 markedly increased in the PCa group with Gleason score of 5 - 6 (GS5-6) but significantly decreased in the GS8-9 group. This malignancy grade-dependent K(+)-channel expression pattern may provide a convenient marker to understand PCa progression level.

摘要

钾离子通道是几种癌症类型进展过程中的关键分子,被认为是癌症治疗的潜在靶点。我们通过实时聚合酶链反应检测了人类前列腺癌(PCa)针吸活检样本中电压门控性(K(v))、钙激活(K(Ca))和双孔结构域(K(2P))钾离子通道亚型的基因表达,并将其与PCa上皮细胞系中的表达进行比较。在Gleason评分为5 - 6(GS5-6)的PCa组中,K(v)1.3、K(Ca)1.1、K(Ca)3.1和K(2P)1的表达显著增加,但在GS8-9组中显著降低。这种恶性程度依赖性的钾离子通道表达模式可能为了解PCa进展水平提供一个便捷的标志物。

相似文献

1
Malignancy grade-dependent expression of K+-channel subtypes in human prostate cancer.人前列腺癌中钾通道亚型的恶性程度依赖性表达
J Pharmacol Sci. 2009 Jan;109(1):148-51. doi: 10.1254/jphs.08208sc. Epub 2009 Jan 8.
2
Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.Kv1.3电压门控钾离子通道亚基在大鼠前列腺癌细胞系中的主要表达:电生理学、药理学及分子特征分析
Pflugers Arch. 2003 Aug;446(5):559-71. doi: 10.1007/s00424-003-1077-0. Epub 2003 Jul 1.
3
Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.前列腺癌中候选易感基因HNF1β和CtBP2的表达模式:与肿瘤进展的关联
Urol Oncol. 2014 May;32(4):426-32. doi: 10.1016/j.urolonc.2013.09.006. Epub 2013 Dec 12.
4
Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.运用基于“Light-Cycler”的定量实时聚合酶链反应检测耻骨后根治性前列腺切除术和经尿道前列腺电切术前后的前列腺特异性抗原RNA
Urology. 2001 Nov;58(5):815-20. doi: 10.1016/s0090-4295(01)01351-6.
5
Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.DNA 激活的蛋白激酶催化多肽的下调可减弱肿瘤进展,并且是前列腺癌生存的独立预后预测指标。
Urol Oncol. 2017 Mar;35(3):111.e15-111.e23. doi: 10.1016/j.urolonc.2016.10.012. Epub 2016 Nov 14.
6
Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.生存素及其剪接异构体的基因表达与前列腺癌的增殖和侵袭性表型相关。
Urology. 2008 Dec;72(6):1229-33. doi: 10.1016/j.urology.2007.12.064. Epub 2008 Mar 12.
7
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.一种新型尿液外泌体基因表达检测方法可预测初始活检中的高级别前列腺癌。
JAMA Oncol. 2016 Jul 1;2(7):882-9. doi: 10.1001/jamaoncol.2016.0097.
8
Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.接受雄激素剥夺治疗的晚期前列腺癌患者中,微小RNA-21表达与临床病理特征及疾病进展风险的相关性
Prostate. 2016 Aug;76(11):986-93. doi: 10.1002/pros.23187. Epub 2016 Apr 4.
9
Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.良性前列腺增生和/或前列腺癌患者外周血中前列腺干细胞抗原(PSCA)mRNA的表达
Med Oncol. 2015 Mar;32(3):74. doi: 10.1007/s12032-015-0529-7. Epub 2015 Feb 20.
10
Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.血栓反应蛋白 2 在前列腺癌和良性前列腺增生中的表达分析。
Exp Mol Pathol. 2013 Jun;94(3):438-44. doi: 10.1016/j.yexmp.2013.02.002. Epub 2013 Mar 5.

引用本文的文献

1
Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.细胞内酸性环境会阻碍利鲁唑和SKA - 31对KCa3.1的激活作用。
Front Pharmacol. 2024 Apr 4;15:1380655. doi: 10.3389/fphar.2024.1380655. eCollection 2024.
2
The Role οf Ion Channels in the Development and Progression of Prostate Cancer.离子通道在前列腺癌发生发展中的作用
Mol Diagn Ther. 2023 Mar;27(2):227-242. doi: 10.1007/s40291-022-00636-9. Epub 2023 Jan 4.
3
Imaging of K 3.1 Channels in Tumor Cells with PET and Small-Molecule Fluorescent Probes.利用正电子发射断层扫描和小分子荧光探针对肿瘤细胞中 K 3.1 通道的成像。
ChemMedChem. 2023 Jan 17;18(2):e202200551. doi: 10.1002/cmdc.202200551. Epub 2022 Nov 22.
4
Ca -activated K channel K 1.1 as a therapeutic target to overcome chemoresistance in three-dimensional sarcoma spheroid models.钙激活钾通道 K1.1 作为克服三维肉瘤球体模型中化疗耐药性的治疗靶点。
Cancer Sci. 2021 Sep;112(9):3769-3783. doi: 10.1111/cas.15046. Epub 2021 Jul 16.
5
KCNN4 induces multiple chemoresistance in breast cancer by regulating BCL2A1.KCNN4通过调节BCL2A1诱导乳腺癌产生多重化疗耐药性。
Am J Cancer Res. 2020 Oct 1;10(10):3302-3315. eCollection 2020.
6
Modulatory Effect of Selected Dietary Phytochemicals on Delayed Rectifier K Current in Human Prostate Cancer Cells.选定膳食植物化学物对人前列腺癌细胞延迟整流钾电流的调节作用。
J Membr Biol. 2019 Jun;252(2-3):195-206. doi: 10.1007/s00232-019-00070-9. Epub 2019 Jun 4.
7
Transcriptional Repression and Protein Degradation of the Ca-Activated K Channel K1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.雄激素受体抑制对人乳腺癌细胞中钙激活钾通道K1.1的转录抑制和蛋白质降解作用
Front Physiol. 2018 Apr 16;9:312. doi: 10.3389/fphys.2018.00312. eCollection 2018.
8
KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.KCNN4和S100A14可作为浆液性卵巢癌理想减瘤患者复发的预测指标。
Oncotarget. 2016 Jul 12;7(28):43924-43938. doi: 10.18632/oncotarget.9721.
9
Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells.组蛋白去乙酰化酶抑制作用下调人乳腺癌细胞钙激活钾通道 KC a3.1。
Pharmacol Res Perspect. 2016 Mar 17;4(2):e00228. doi: 10.1002/prp2.228. eCollection 2016 Apr.
10
KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.KCa3.1 通过 PI3k/Akt/mTOR 信号通路介导糖尿病肾脏管状自噬功能障碍。
Sci Rep. 2016 Mar 31;6:23884. doi: 10.1038/srep23884.